2024-09-01 - Analysis Report
## PFE Stock Analysis:

**Company Overview:** Pfizer Inc. is a multinational pharmaceutical corporation that develops, manufactures, and distributes medicines and vaccines.

**Performance Comparison to S&P 500:**

* **PFE's cumulative return:** -26.27%
* **VOO's cumulative return:** 89.66%
* **Performance Difference:** -115.93% (relative divergence: 1.28)

This means that PFE has significantly underperformed the S&P 500 over the analyzed period.

**Recent Price Movements:**

* **Closing price:** $29.01
* **5-day moving average:** $28.84
* **20-day moving average:** $28.85
* **60-day moving average:** $28.80

PFE's price is currently above its 5-day, 20-day and 60-day moving averages, suggesting a possible upward trend. 

**Technical Indicators:**

* **RSI:** 60.69 - This suggests the stock is in neutral territory.
* **PPO:** -0.02 - This indicates a slight bearish trend.
* **Delta_Previous_Relative_Divergence:** -11.82 - This suggests a short-term downward trend.

**Expected Return:** 0.0% - Based on current market conditions, there is no significant expected return for PFE.

**Recent Earnings Performance:**

| Date | EPS | Estimated EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

The most recent earnings report (2024-07-30) showed an EPS of 0.6, exceeding the estimated EPS of 0.458. This positive earnings surprise may indicate a stronger than expected financial performance.

**Overall Analysis:**

PFE's performance has been significantly lagging behind the S&P 500. However, recent price movements and earnings performance show some positive signs. While technical indicators indicate a possible short-term downtrend, the stock is currently trading above its moving averages and the recent earnings report was positive. Investors should monitor the company's future earnings releases and overall market conditions to gauge the potential for future growth. 

**Disclaimer:** This analysis is for informational purposes only and does not constitute financial advice. Please consult a financial professional before making any investment decisions. 
